Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

28.30
+0.75002.72%
Post-market: 28.300.00000.00%19:57 EDT
Volume:3.77M
Turnover:107.05M
Market Cap:3.18B
PE:-24.54
High:28.98
Open:28.27
Low:27.68
Close:27.55
Loading ...

Viking Therapeutics put volume heavy and directionally bearish

TIPRANKS
·
06 May

Why Viking Therapeutics Stock Was Victorious This Week

Motley Fool
·
03 May

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

Motley Fool
·
02 May

Where Will Viking Therapeutics Be in 3 Years?

Motley Fool
·
02 May

Viking Therapeutics Inc. Unveils Corporate Presentation on Advancements in Metabolic and Endocrine Disease Therapies

Reuters
·
02 May

Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

Motley Fool
·
30 Apr

Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain

Motley Fool
·
30 Apr

Why Viking Therapeutics Stock Popped Again Today

Motley Fool
·
30 Apr

Cantor Fitzgerald Initiates Viking Therapeutics at Overweight With $104 Price Target

MT Newswires Live
·
29 Apr

Viking Therapeutics Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
29 Apr

Viking Therapeutics Price Target Cut to $75.00/Share From $95.00 by Truist Securities

Dow Jones
·
28 Apr

Viking Therapeutics price target lowered to $75 from $95 at Truist

TIPRANKS
·
28 Apr

Viking Therapeutics Inc : Truist Securities Cuts Target Price to $75 From $95

THOMSON REUTERS
·
28 Apr

Truist Securities Cuts Viking Therapeutics Price Target to $75 From $95, Maintains Buy Rating

MT Newswires Live
·
25 Apr

Viking Therapeutics: Promising Pipeline and Strategic Execution Drive Buy Rating

TIPRANKS
·
25 Apr

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss for Q1 2025

Simply Wall St.
·
25 Apr

Viking Therapeutics Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
25 Apr

Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?

Zacks
·
24 Apr

Viking Therapeutics price target lowered to $85 from $96 at B. Riley

TIPRANKS
·
24 Apr

B. Riley Adjusts Price Target on Viking Therapeutics to $85 From $96, Maintains Buy Rating

MT Newswires Live
·
24 Apr